FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

432005001: Eltrombopag (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2746127011 Eltrombopag (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2771883019 Eltrombopag en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
58391000195115 eltrombopag it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
808261000172117 eltrombopag fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
73481000195118 Eltrombopag de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eltrombopag (substance) Is a Platelet-derived growth factor false Inferred relationship Some
Eltrombopag (substance) Is a Pyrazole false Inferred relationship Some
Eltrombopag (substance) Is a Hydrazine false Inferred relationship Some
Eltrombopag (substance) Is a Thrombopoietin receptor agonist true Inferred relationship Some
Eltrombopag (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Thrombopoietin receptor agonist (disposition) true Inferred relationship Some
Eltrombopag (substance) Is a Benzoic acid and/or benzoic acid derivative (substance) true Inferred relationship Some
Eltrombopag (substance) Is a Hydrazine and/or hydrazine derivative true Inferred relationship Some
Eltrombopag (substance) Is a Pyrazole and/or pyrazole derivative (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Eltrombopag olamine (substance) Is a False Eltrombopag (substance) Inferred relationship Some
Product containing precisely eltrombopag 25 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eltrombopag (substance) Inferred relationship Some
Product containing eltrombopag (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Eltrombopag (substance) Inferred relationship Some 1
Product containing precisely eltrombopag 50 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eltrombopag (substance) Inferred relationship Some
Product containing precisely eltrombopag 75 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eltrombopag (substance) Inferred relationship Some
Product containing precisely eltrombopag 50 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eltrombopag (substance) Inferred relationship Some 1
Product containing precisely eltrombopag 50 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Eltrombopag (substance) Inferred relationship Some 1
Product containing precisely eltrombopag 25 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eltrombopag (substance) Inferred relationship Some 1
Product containing precisely eltrombopag 25 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Eltrombopag (substance) Inferred relationship Some 1
Product containing precisely eltrombopag 75 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eltrombopag (substance) Inferred relationship Some 1
Product containing precisely eltrombopag 75 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Eltrombopag (substance) Inferred relationship Some 1
Product containing precisely eltrombopag 50 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Eltrombopag (substance) Inferred relationship Some 1
Product containing precisely eltrombopag 25 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Eltrombopag (substance) Inferred relationship Some 1
Product containing precisely eltrombopag 75 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Eltrombopag (substance) Inferred relationship Some 1
Product containing eltrombopag in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Eltrombopag (substance) Inferred relationship Some 1
Product containing only eltrombopag (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Eltrombopag (substance) Inferred relationship Some 1
Eltrombopag only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Eltrombopag (substance) Inferred relationship Some 1
Product containing precisely eltrombopag (as eltrombopag olamine) 25 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Eltrombopag (substance) Inferred relationship Some 1
Eltrombopag (as eltrombopag olamine) 12.5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Eltrombopag (substance) Inferred relationship Some 1
Eltrombopag (as eltrombopag olamine) 50 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Eltrombopag (substance) Inferred relationship Some 1
Product containing precisely eltrombopag (as eltrombopag olamine) 75 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Eltrombopag (substance) Inferred relationship Some 1
Eltrombopag olamine (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Eltrombopag (substance) Inferred relationship Some

This concept is not in any reference sets

Back to Start